Clinical Trial Detail

NCT ID NCT01351909
Title Cyclophosphamide With or Without Veliparib in Treating Patients With Locally Advanced or Metastatic Breast Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements yes
Sponsors National Cancer Institute (NCI)
Indications

Her2-receptor negative breast cancer

Therapies

Cyclophosphamide

Veliparib

Age Groups: adult

Additional content available in CKB BOOST